LAPTM5 and renal cell carcinoma: Another possibility that was not investigated in the current study is the tight correlation between LAPTM5 and immune-related or chemotactic pathways, like T/B cell antigen receptor (TCR/BCR)- and interleukin (IL)-associated pathways, in RCC.